MGLN Magellan Health, Inc.

Magellan Health, Inc. engages in the business of healthcare management. It operates through the following segments: Healthcare, Pharmacy Management and Corporate. The Healthcare segment comprises of the Commercial and Government reporting units. The Pharmacy Management segment offers products and solutions that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit. The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Phoenix, AZ.

Company profile

Ticker

MGLN

Exchange

NASDAQ

Website

www.magellanhealth.com

CEO

Kenneth J. Fasola

Incorporated in

Delaware

Location

Arizona

Fiscal year end

Dec 31

Sector

Health Services > Managed Health Care

Industry (SEC)

Services - Hospitals

MEDNAX • Encompass Health • Select Medical • JRSIS HEALTH CARE • Spine Injury Solutions ...

Former names

Charter Medical Corp, Magellan Health Services Inc

SEC CIK

0000019411

Corporate docs

Articles of Incorporation & Bylaws

IRS number

581076937

MGLN stock data

S&P 500

1M 1Y 2Y 5Y

Calendar

11 May 20

11 Jul 20

31 Dec 20

News

Company financial data Financial data

Chart MGLN financial data

Quarter (USD)	Mar 20	Dec 19	Sep 19	Jun 19
Revenue	1.79B	1.8B	1.83B	1.79B
Net income	18.25M	20.58M	21.27M	13.61M
Diluted EPS	0.73	0.83	0.86	0.56
Net profit margin	1.02%	1.14%	1.16%	0.76%
Net change in cash	58.71M	307.75M	13.2M	-9.3M
Cash on hand	383.96M	325.25M	17.5M	4.3M
Cost of revenue	486.14M	465.61M	482.28M	461.19M

Annual (USD)	Dec 19	Dec 18	Dec 17	Dec 16
Revenue	7.16B	7.31B	5.84B	4.84B
Net income	55.9M	24.18M	110.14M	75.79M
Diluted EPS	2.28	0.97	4.51	3.22
Net profit margin	0.78%	0.33%	1.89%	1.57%
Net change in cash	316.45M	-105.9M	-12.3M	-33.2M
Cash on hand	325.25M	8.8M	114.7M	127M
Cost of revenue	1.9B	2.28B	2.21B	1.82B

Financial data from company earnings reports

Recent insider trades

MGLN insider ownership history Insider history

Date	Owner	Security	Transaction	Code	10b5-1	#Shares	#Remaining
17 Jun 20	Abbott Swati Bargotra	Ordinary Common Stock, $0.01 par value	Grant	Aquire A	No	2,122	6,058
17 Jun 20	Norwalk Leslie V	Ordinary Common Stock, $0.01 par value	Grant	Aquire A	No	2,122	4,909
17 Jun 20	Mackenzie Gregory Scott	Ordinary Common Stock, $0.01 par value	Grant	Aquire A	No	2,122	9,805

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2020

MGLN institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	169	207	-18.4%
Opened positions	13	29	-55.2%
Closed positions	51	30	+70.0%
Increased positions	59	66	-10.6%
Reduced positions	68	74	-8.1%

13F shares	Current	Prev Q	Change
Total value	2.83B	4.67B	-39.4%
Total shares	24.74M	24.51M	+0.9%
Total puts	25.5K	52.2K	-51.1%
Total calls	161.8K	114.8K	+40.9%
Total put/call ratio	0.2	0.5	-65.3%

Largest owners	Shares	Value	Change
BLK BlackRock	3.4M	$163.66M	-2.0%
Vanguard	2.42M	$116.64M	+2.3%
Starboard Value	2.37M	$113.98M	0.0%
Dimensional Fund Advisors	2.06M	$99.14M	+0.7%
Victory Capital Management	1.37M	$66.11M	+13.6%
JPM JPMorgan Chase & Co.	1.06M	$51.1M	+28.7%
STT State Street	934.78K	$44.97M	+5.1%
Renaissance Technologies	814.02K	$39.16M	+20.8%
NTRS Northern Trust	765.91K	$36.85M	+0.3%
Brown Advisory	594.4K	$28.6M	+24.8%

Largest transactions	Shares	Bought/sold	Change
Point72 Asset Management	560.25K	+429.57K	+328.7%
Norges Bank	0	-349.99K	EXIT
WHG Westwood	261.29K	+261.29K	NEW
JPM JPMorgan Chase & Co.	1.06M	+237.03K	+28.7%
MS Morgan Stanley	61.62K	-181.88K	-74.7%
MNGPF Man	71.12K	-177.18K	-71.4%
Victory Capital Management	1.37M	+164.92K	+13.6%
Millennium Management	209.53K	-157.27K	-42.9%
Renaissance Technologies	814.02K	+140.2K	+20.8%
Nuveen Asset Management	271.16K	+134.33K	+98.2%

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Cigna

Management Discussion

Net revenue, cost of care, cost of goods sold, and direct service costs and other operating expense variances are addressed within the segment results that follow.
Depreciation and amortization expense decreased by 0.9 percent or $1.1 million from 2018 to 2019, primarily due to asset maturation after 2018.
Interest expense increased by $0.8 million from 2018 to 2019 mainly due to higher interest rates.

Content analysis ?

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: absence, accommodate, accuracy, acute, agreed, aid, alternative, Antitrust, attack, attempting, attention, attrition, breakdown, consummation, country, customary, cyber, cybersecurity, damage, degree, delegate, description, detective, difficult, disruption, diversion, divestiture, drawdown, driver, emergency, entirety, epidemic, error, evolving, exfiltration, exit, experienced, exposure, extraordinary, fail, forecast, forecasted, foregoing, forensic, GDPR, geography, global, hereto, HIPAA, human, incident, increasingly, indemnified, instituted, interruption, location, lookback, lost, macroeconomic, maintenance, malfeasance, minimize, misplaced, Molina, multiple, notifying, outage, outbreak, oversee, pandemic, pendency, penetrating, personal, phishing, platform, political, proliferation, proprietary, prove, purport, qualified, quantifiable, quantified, ransomware, rapidly, recent, recently, recession, recoded, regular, reliably, relief, rest, resumption, retired, retirement, rigor, routine, routinely, significantly, spread, store, strategic, strategically, suffered, system, tangible, temporary, terrorism, timeframe, transmit, turn, unexpected, unsuccessful, upgrade, vandalism, vendor, vulnerable, waiting, Waiver, war, widespread, world, write

Removed: advanced, agile, assessing, capable, combining, comparative, delivering, Depending, disclose, dispute, estate, excellence, Farm, fastest, generate, leader, leasing, lower, matter, Mortgage, package, pertaining, prepare, prescribed, producing, real, recognize, ultimate, undiscounted, unrecorded

From filing 10-Q 2020 Q1